Holden writes, "Resilient Lifescience co-founder Charlie Proctor and I became alarmed by the 22% surge in synthetic opioid deaths during the COVID-19 pandemic and set out to leverage our experience in remote patient monitoring and computer science to develop a solution — a wearable medical device designed to detect and reverse opioid overdoses. Read on to learn how Resilient Lifescience is making a difference!